Search results for " Humans"

showing 10 items of 2466 documents

Los canecillos de la Capilla del Cementerio de San Juan del Hospital de Valencia

2020

In the medieval cemetery of the Historic Site of San Juan del Hospital of Valencia is housed a small funeral chapel founded in the late thirteenth century by the knight Arnau de Romaní. Along its cornice there are a series of heads of animals and humans that are one of the few sculptural vestiges inserted into the Romanesque iconographic tradition that are preserved in the city. So far they have not aroused the interest of specialists and no one has dedicated a detailed study to these curious and interesting images located in the marginal spaces of such a beautiful building. This article aims to complete this gap addressing the study of the corbels of the small temple, projecting a thematic…

UNESCO::CIENCIAS DE LAS ARTES Y LAS LETRASprojecting a thematic tour both for its iconography and for its symbolic and functional meaning. Iglesia de San Juan del Hospital / Hospitalarios / Canecillos / Escultura / RománicoChurch of San Juan del Hospital / Hospitalers / Corbels / Sculpture / Romanesque. 9 26Emilio Jesús In the medieval cemetery of the Historic Site of San Juan del Hospital of Valencia is housed a small funeral chapel founded in the late thirteenth century by the knight Arnau de Romaní. Along its cornice there are a series of heads of animals and humans that are one of the few sculptural vestiges inserted into the Romanesque iconographic tradition that are preserved in the city. So far they have not aroused the interest of specialists and no one has dedicated a detailed study to these curious and interesting images located in the marginal spaces of such a beautiful building. This article aims to complete this gap addressing the study of the corbels of the small temple:CIENCIAS DE LAS ARTES Y LAS LETRAS [UNESCO]0211-5808 9678 Archivo de arte valenciano 564145 2020 101 7707052 Los canecillos de la Capilla del Cementerio de San Juan del Hospital de Valencia Díaz García
researchProduct

Tema 10. Estratègies de recursos humans. Direcció Estratégica

2019

Opcions estratègiques de recursos humans. Selecció d'estratègies de recursos humans per millorar els resultats. Desenvolupament d’habilitats i orientació conductual.

UNESCO::CIENCIAS ECONÓMICAS::Organización y dirección de empresas ::Organización de recursos humanosdirecció d'empresesrecursos humans
researchProduct

Esquemes de Direcció Estratègica de l'Empresa

2016

El document forma part dels materials docents programats mitjançant l'ajut del Servei de Política Lingüística de la Universitat de València La matèria se centra en l’estudi dels plantejaments actuals de la direcció d’empreses, aplicant un enfocament global i integrador de l'anàlisi, de les decisions i de les accions de caràcter estratègic. A través de l'estratègia, els directius tracten de definir els objectius i d’orientar la trajectòria de les empreses, buscant l’equilibri entre el desenvolupament i la supervivència a llarg termini; i la consecució d’altres objectius de tota mena a mitjà i curt termini. Per a aplicar aquesta metodologia de direcció en la pràctica professional, cal entendr…

UNESCO::CIENCIAS ECONÓMICAS::Organización y dirección de empresasprocés estratègicestratègia de recursos humansDirecció Estratègicaestratègia corporativa
researchProduct

El Pacte Internacional de Drets Econòmics, Socials i Culturals de 1966 i el seu Protocol Facultatiu de 2008

2023

Introducción al Pacte Internacional de Drets Econòmics, Socials i Culturals de 1966 i el seu Protocol Facultatiu de 2008

UNESCO::CIENCIAS JURÍDICAS Y DERECHOdrets humans
researchProduct

El Conveni Europeu per a la Protecció dels Drets Humans i de les Llibertats Fonamentals, de 1950

2023

El Conveni Europeu per a la Protecció dels Drets Humans i de les Llibertats Fonamentals, de 1950. 1. Introducció. 2. Drets protegits. 3. Control del compliment. The 1950 European Convention for the Protection of Human Rights and Fundamental Freedoms. 1. Introduction. 2. Protected Rights. 3. Compliance monitoring.

UNESCO::CIENCIAS JURÍDICAS Y DERECHO::Derecho internacionaldret Internacionalconsell d'europadret internacional dels drets humansconveni europeu de drets humans
researchProduct

Filosofia moral i ètiques aplicades II

2014

El document forma part dels materials docents programats mitjançant l'ajut del Servei de Política Lingüística de la Universitat de València. L'assignatura obligatòria "Filosofia Moral i Ètiques Aplicades II" està concebuda per a desenvolupar continguts temàtics amb els quals l'estudiant obté un marc de referència d'interès per al desenvolupament del conjunt de competències generals del títol de Graduat / a en Filosofia. El temari presenta diferents dimensions de l'ètica, els seus mètodes, les classificacions i els models de fonamentació teòrica més rellevants, els trets d'una societat pluralista i democràtica, l'ètica cívica que la fa possible i diferents ètiques aplicades que sorgeixen de …

UNESCO::ÉTICA::Ética de grupo::Ética transnacionalUNESCO::ÉTICA::Ética de individuos::Ética filosóficabioèticaUNESCO::ÉTICA::Otras especialidades relacionadas con la éticaUNESCO::ÉTICA::Ética de grupo::Ética de la cienciadrets humansfilosofia moralUNESCO::ÉTICA::Ética de grupo::Ética económicaUNESCO::ÉTICA::La ética en perspectivaètica dels mitjans de comunicacióètica empresarialètica del desenvolupamentètica de la ciènciaètica cívicacosmopolitismeètica
researchProduct

Impact of the COVID-19 pandemic on urological practice in emergency departments in Italy

2020

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and the disease it causes, coronavirus disease 2019 (COVID-19), are causing a rapid and tragic health emergency worldwide [1,2]. Italy was the first European country to experience a virus outbreak, starting on 21 February 2020. It resulted in a national quarantine, and the official lockdown of the country’s non-essential businesses and services began on 9 March 2020. Although several reports are available in the literature providing recommendations for the reorganization of clinical and surgical activities [3–7], to our knowledge, no data are available on the effects of the COVID-19 pandemic on the outcomes of other medical conditi…

Urologic Diseasesmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Pneumonia ViralMEDLINE.SARS‐CoV‐2BetacoronavirusResearch CorrespondencePandemicmedicineSARS‐CoV‐2; coronavirus disease 2019 (COVID‐19); health emergency; urologyHumansurologyPandemicsReferral and Consultationbiologybusiness.industryViral EpidemiologySARS-CoV-2Incidence (epidemiology)IncidenceCOVID-19medicine.diseasebiology.organism_classificationPneumoniahealth emergencyItalyEmergency medicineUrologic diseasecoronavirus disease 2019 (COVID‐19)businessCoronavirus InfectionsEmergency Service HospitalCoronavirus Infections Emergency Service Hospital Humans Incidence Italy Pneumonia Viral Referral and Consultation Urologic Diseases Betacoronavirus PandemicsBetacoronavirus
researchProduct

Robotic versus laparoscopic radical hysterectomy in early cervical cancer: A case matched control study

2018

Abstract Background This study aims at evaluating the feasibility, surgical outcome and oncological results observed after robotic radical hysterectomy (RH) compared to laparoscopy for patients with early stage cervical cancer (ECC) patients. Methods Between January 2010 and October 2016, 210 patients underwent RH for treatment of ECC: 70 underwent robotic approach (Cases), and 140 underwent laparoscopic approach (Controls). Results There was no statistically significant difference between the two approaches with regard to clinical patient characteristics and in terms of extent of RH and rate of pelvic and aortic lymphadenectomy. Operative time was significantly longer in the robotic versus…

Uterine Cervical NeoplasmTime Factorsmedicine.medical_treatmentEarly stage cervical cancerUterine Cervical Neoplasms0302 clinical medicinePostoperative ComplicationsRetrospective StudieLaparotomy80 and overMedicineEarly Detection of CancerEarly stage cervical cancer; Laparoscopy; Robotic surgery; Adult; Aged; Aged 80 and over; Female; Humans; Hysterectomy; Incidence; Italy; Laparoscopy; Middle Aged; Postoperative Complications; Retrospective Studies; Robotics; Survival Rate; Time Factors; Uterine Cervical Neoplasms; Young Adult; Early Detection of Cancer; Neoplasm Staging; Surgery; OncologyAged 80 and over030219 obstetrics & reproductive medicineIncidenceGeneral MedicineRoboticsMiddle AgedSurvival RateOncologyItaly030220 oncology & carcinogenesisFemaleHumanAdultmedicine.medical_specialtyTime FactorHysterectomy03 medical and health sciencesYoung AdultHumansRobotic surgeryRadical surgeryRadical HysterectomySurvival rateRetrospective StudiesAgedNeoplasm StagingHysterectomybusiness.industryRobotic surgeryPerioperativeSurgeryRoboticSettore MED/40 - GINECOLOGIA E OSTETRICIASurgeryLymphadenectomyLaparoscopyPostoperative Complicationbusiness
researchProduct

VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells

2014

Abstract Anti-VEGF therapy perturbs tumor metabolism, severely impairing oxygen, glucose, and ATP levels. In this study, we investigated the effects of anti-VEGF therapy in multiple experimental tumor models that differ in their glycolytic phenotypes to gain insights into optimal modulation of the metabolic features of this therapy. Prolonged treatments induced vascular regression and necrosis in tumor xenograft models, with highly glycolytic tumors becoming treatment resistant more rapidly than poorly glycolytic tumors. By PET imaging, prolonged treatments yielded an increase in both hypoxic and proliferative regions of tumors. A selection for highly glycolytic cells was noted and this met…

Vascular Endothelial Growth Factor ACancer ResearchPathologymedicine.medical_specialtyNecrosismedicine.medical_treatmentAngiogenesis InhibitorsMice SCIDBiologySCIDAntibodies Monoclonal HumanizedAntibodiesCell LineTargeted therapyMiceRandom AllocationCell Line TumorNeoplasmsMonoclonalAngiogenesis Inhibitors; Animals; Antibodies Monoclonal Humanized; Bevacizumab; Cell Line Tumor; Female; Glycolysis; Humans; MCF-7 Cells; Mice; Mice Inbred BALB C; Mice SCID; Molecular Targeted Therapy; Neoplasms; Phenotype; Random Allocation; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor AssaysmedicineAnimalsHumansGlycolysisMolecular Targeted Therapycancer-cellAnti-VEGF therapyHumanizedInbred BALB CMED/36 - DIAGNOSTICA PER IMMAGINI E RADIOTERAPIAMice Inbred BALB CTumorpositron emission tomography antiangiogenesis glucose metabolism hypoxiaXenograft Model Antitumor AssaysPhenotypeBlockadeBevacizumabVascular endothelial growth factor APhenotypeOncologyCell cultureMonoclonalMCF-7 CellsCancer researchMED/06 - ONCOLOGIA MEDICAFemalemedicine.symptomGlycolysis
researchProduct

Anticancer therapy-induced vascular toxicity: VEGF inhibition and beyond

2017

Cardiotoxicity induced by chemotherapeutic agents and radiotherapy is a growing problem. In recent years, an increasing number of new drugs with targeted action have been designed. These molecules, such as monoclonal antibodies and tyrosine kinase inhibitors, can cause different type of toxicities compared to traditional chemotherapy. However, they can also cause cardiac complications such as heart failure, arterial hypertension, QT interval prolongation and arrhythmias. Currently, a field of intense research is the vascular toxicity induced by new biologic drugs, particularly those which inhibit vascular endothelial growth factor (VEGF) and its receptor (VEGF-R) and other tyrosine kinases.…

Vascular Endothelial Growth Factor APathologymedicine.medical_specialtyHeart Diseasesmedicine.medical_treatmentVascular toxicity VEGF cardiotoxicity new target therapy chemotherapy radiotherapy cardio-oncologyAntineoplastic Agents030204 cardiovascular system & hematologyQT intervalCardiooncology03 medical and health scienceschemistry.chemical_compoundCardio-oncology; Cardiotoxicity; Chemotherapy; New target therapy; Radiotherapy; Vascular toxicity; VEGF; Medicine (all); Cardiology and Cardiovascular Medicine0302 clinical medicineVascularReceptorsmedicineAnimalsHumansChemotherapyEndotheliumNew target therapyChemotherapyCardiotoxicityRadiotherapybusiness.industryVascular Endothelial Growth FactorMedicine (all)Cardiooncology; Vascular toxicity; New target therapyCardio-oncology; Cardiotoxicity; Chemotherapy; New target therapy; Radiotherapy; Vascular toxicity; VEGF; Animals; Antineoplastic Agents; Cardiotoxicity; Endothelium Vascular; Heart Diseases; Humans; Reactive Oxygen Species; Receptors Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor Amedicine.diseaseVEGFCardiotoxicityVascular endothelial growth factorRadiation therapyCardio-oncologyVascular endothelial growth factor AReceptors Vascular Endothelial Growth Factorchemistry030220 oncology & carcinogenesisHeart failureCancer researchEndothelium VascularVascular toxicityReactive Oxygen SpeciesCardiology and Cardiovascular MedicinebusinessTyrosine kinaseInternational Journal of Cardiology
researchProduct